Key Financial Data Of Group

Solasia Pharma K.K. - Filing #7311866

Concept 2024-01-01 to
2024-06-30
As at
2024-06-30
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-06-30
As at
2023-06-30
Key financial data of group
Business results of group
Revenue
72,000,000 JPY
617,000,000 JPY
529,000,000 JPY
Profit (loss) before tax
-627,000,000 JPY
-1,135,000,000 JPY
-450,000,000 JPY
Profit (loss), attributable to owners of parent
-611,000,000 JPY
-1,112,000,000 JPY
-437,000,000 JPY
Comprehensive income, attributable to owners of parent
-600,000,000 JPY
-1,103,000,000 JPY
-430,000,000 JPY
Equity attributable to owners of parent
1,965,000,000 JPY
1,875,000,000 JPY
2,233,000,000 JPY
Total assets
2,299,000,000 JPY
2,229,000,000 JPY
2,678,000,000 JPY
Basic earnings (loss) per share
-3.35
-6.62
-2.61
Diluted earnings (loss) per share
-3.35
-6.62
-2.61
Ratio of owners' equity to gross assets
0.855 xbrli:pure
0.841 xbrli:pure
0.833 xbrli:pure
Cash flows from (used in) operating activities
-474,000,000 JPY
-359,000,000 JPY
-330,000,000 JPY
Cash flows from (used in) investing activities
0 JPY
0 JPY
0 JPY
Cash flows from (used in) financing activities
675,000,000 JPY
275,000,000 JPY
-23,000,000 JPY
Cash and cash equivalents
942,000,000 JPY
728,000,000 JPY
453,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.